Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

PURPOSE: The phase III North American Intergroup E2496 Trial (Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma) compared doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) with mechlorethamine, doxorubicin, vincristine, bleomycin,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Advani, Ranjana H., Hong, Fangxin, Fisher, Richard I., Bartlett, Nancy L., Robinson, K. Sue, Gascoyne, Randy D., Wagner, Henry, Stiff, Patrick J., Cheson, Bruce D., Stewart, Douglas A., Gordon, Leo I., Kahl, Brad S., Friedberg, Jonathan W., Blum, Kristie A., Habermann, Thomas M., Tuscano, Joseph M., Hoppe, Richard T., Horning, Sandra J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451176/
https://ncbi.nlm.nih.gov/pubmed/25897153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.8138
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars